NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

There may be more to this Merck/Moderna “personalized cancer vaccine” news that just so happened to coincidently occur now, right before a potential announcement that Northwest Bio is actually seeking approval and is nearly ready to begin commercialization of a personalized cancer vaccine.

Merck’s collaboration with Moderna to develop mRNA cancer vaccines started back in 2016, and has expanded several times since then. This latest collaboration news isn’t really as big a deal as it’s being made to sound. Perhaps they’re trying to steal some thunder? Hmmmm.

Merck Invests in RNA Startup to Target Cancer
If it works, mRNA therapy could provide a simple way to create customized cancer vaccines.
By Ryan Crossarchive page
July 5, 2016
https://www.technologyreview.com/2016/07/05/158983/merck-invests-in-rna-startup-to-target-cancer/


Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
May 3, 2018
https://www.merck.com/news/moderna-and-merck-expand-mrna-cancer-vaccines-collaboration/


Merck Announces Sale of its Direct Equity Investment in Moderna
December 2, 2020
Merck and Moderna continue to collaborate on the development of personalized cancer vaccines as well as a cancer vaccine that encodes the four most common KRAS mutations.
https://www.merck.com/news/merck-announces-sale-of-its-direct-equity-investment-in-moderna/


Merck opts to develop, sell cancer vaccine with Moderna
Oct 12, 2022
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-opts-jointly-develop-cancer-vaccine-with-moderna-2022-10-12/